Eli Lilly will offer a half-off version of its popular insulin drug Humalog

Amid increasing pressure on the pharmaceutical industry to lower prices, drugmaker Eli Lilly is planning to sell a cheaper version of Humalog, its popular insulin product.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.